Found 5 matching trials
Proglumide and Chemotherapy for Metastatic Pancreatic Cancer
PHASE2This is a Phase 2 study with an open labelled lead-in study to approximatel...
Status
Active Not Recruiting
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Single-dose PK Assessment of Oral Proglumide in Those With Hepatic Impairment
EARLY_PHASE1Proglumide is an oral cholecystokinin (CCK) receptor antagonist that has be...
Location
Georgetown University
Proglumide With Gemcitabine and Nab-Paclitaxel in PatientsWith Metastatic Pancreatic Ductal Adenocarcinoma
PHASE1This is a Phase I open labelled study to treat patients with metastatic pan...
Location
Lombardi Comprehensive Cancer Center, Georgetown University
Safety and Tolerability of Oral Proglumide for NASH
PHASE1This study is an open labelled Phase I/II clinical trial, designed to evalu...
Location
Georgetown University
Role of a CCK Receptor Antagonist Proglumide in Management of Chronic Pancreatitis
PHASE1Chronic pancreatitis is a rare but debilitating condition associated with c...
Status
Active Not Recruiting
Location
Georgetown University